Trump’s Rhetorical Pivot On Pharma: The Hucksterism Is Still A Threat

It is nice for pharma CEOs to be called ‘brilliant’ by a President who once said they are ‘getting away with murder.’ But the ‘new’ Trump rhetoric still has major pitfalls for industry – including a fundamental risk of undermining regulatory standards.

Instant success on pill bottle
Pharmaceutical companies had earlier worried that Trump could be too harsh a critic. Now they may worry that the President may oversell their products.

More from Legislation

More from Pink Sheet